semaglutide hospitalizations and in Patients With Obesity and Established Cardiovascular Disease: An Exploratory Analysis of the SELECT Randomized Clinical Trial Semaglutide and NT-proBNP in Obesity-Related

Persistent mild inflammation and changes in the immune system are characteristic features of the aging process and diseases associated with old age (Franceschi et al., 2018

This can be linked to a significant reduction of serine palmitoyl transferase (SPT) protein levels and the downregulation of the ceramide-synthesis enzymes ceramide synthase 5 ( CERS5 ) and delta(4)-desaturase as well as sphingolipid 1 ( DEGS1 ) expression at both messenger-RNA and protein levels

Peptides play many roles and are responsible for many biochemical processes

The post names fasting glucose, insulin levels, and incretin hormone response as measures giving clinical context for how a patient processes semaglutide at a given dose